Cincinnati, Ohio (September 12, 2011) - BioRx, a specialty pharmacy company, has received limited distribution rights from Shire Human Genetic Therapies, Inc. (“Shire HGT”) for its new drug, FIRAZYR® (icatibant injection), which received FDA approval on August 25, 2011. As the only FDA-approved self-injectable treatment for hereditary angioedema (HAE), FIRAZYR offers HAE patients an important new option for treating HAE attacks. Read the rest of this entry »
Philip Rielly and Eric Hill co-founded a small private company and they run it like a small private company. Every decision they make, they ask themselves, “Is this big-corporate stupid?” Read the rest of this entry »
January 10, 2011 (Cincinnati, Ohio) - BioRx announced it has hired Robin R. Johnson, MBA, CPA, as its new Chief Financial Officer. Johnson comes to BioRx from Vohra Health Services of Miami, Florida, the nation’s largest wound care provider, where she served as Interim Chief Financial Officer. At BioRx, Johnson’s responsibilities are to plan, implement, and manage all financial and accounting functions of the company. Read the rest of this entry »
October 5, 2010 (Cincinnati, Ohio) - BioRx, a specialty pharmacy company, has received limited distribution rights from Baxter International Inc. for a new drug, GLASSIA™ Alpha 1-Proteinase Inhibitor (Human)], the first and only liquid, ready-to-use treatment for alpha-1 antitrypsin deficiency (AATD) in the United States. AATD is a genetic disorder that causes low levels of alpha 1-antitrypsin, resulting in emphysema. AATD is also referred to as “genetic” or “congenital” emphysema. Read the rest of this entry »
September 1, 2010 (Cincinnati, Ohio) - BioRx and Hemophilia of North Carolina announce the availability of four 2011 BioRx Educational Scholarships in the amount of $2,000 each to individuals with bleeding disorders. The scholarships will be awarded for the 2011-2012 school year, and the deadline for submitting applications is May 1, 2011. Read the rest of this entry »
BioRx and Hemophilia of North Carolina announce the availability of four 2011 BioRx Educational Scholarships, in the amount of $2,000 each, to individuals with bleeding disorders*. The scholarships will be awarded for the 2011-2012 school year, and the deadline for submitting applications is May 1, 2011. Read the rest of this entry »
August 13, 2010 (Cincinnati, Ohio) - Marcia Larsen has joined BioRx as Director of Managed Care. Her territory includes all states east of the Mississippi River with the exception of Florida. Read the rest of this entry »
July 20, 2010 (Cincinnati, Ohio) – Philip Rielly, President and Co-founder of specialty pharmacy BioRx LLC, has received the Ernst & Young Entrepreneur Of The Year® 2010 Award in the Healthcare category in South Central Ohio and Kentucky. Read the rest of this entry »
